SEARCH · PubMed Health

Results for “PERIODIC DISEASE”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 541 records · Page 30Linked to original sources

PubMed1994

Epidemiology and control of parasites in nomadic situations.

Nomadism is a highly specialised mode of life that enables humans to exploit resources that are widely distributed over space and time. The isolation and remoteness of many nomad populations have limited studies on the macroepidemiology of parasitic infection in nomad populations. From the available information, the influence of a number of factors on the prevalence and transmission of parasitic infections in nomads is discussed. Environmental conditions, especially relative humidity and temperature, profoundly influence parasitic diseases. Human behaviour varies with cultural factors and influences exposure to disease. Periodic movements of nomads may either remove them and their animals from contaminated environments or may bring then into contact, often seasonally, with infections. There may be a strong ecological interdependence between diet and infection and disease in nomadic groups. Finally, the influence of drought can be profound in that seasonal or prolonged drought promotes concentration of populations in small areas or their sedenterisation, often with an increase in parasite transmission. Relevant information that needs to be acquired to develop appropriate practical and cost-effective health and veterinary care and control programmes for nomadic populations and their livestock is outlined.

Africa South of the Sahara↗

PubMed2001

Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus.

R6/2 transgenic mice express exon 1 of the human Huntington's disease (HD) gene with an increased CAG repeat length. They develop a progressive neurological phenotype, die within 12-14 weeks of age and were also found to develop diabetes mellitus. Since R6/2 mice are broadly used to screen for potential therapies in HD, the aim of this study was (a) to search for behavioral tests that are best applicable to monitor the behavioral abnormalities in therapy studies and (b) to investigate the extent to which diabetes influences the disease phenotype. We found that the rotarod test for motor coordination and the open field test for spontaneous explorative behavior were useful to monitor the progressive behavioral deterioration of R6/2 mice. An accelerating rotarod paradigm was superior over testing with a rotarod at various fixed speeds since it leads to similar results with less repetitive daily trials so that exhaustion cannot contribute substantially to their decline in performance. With the Morris water maze, however, it was only possible to monitor cognitive decline in visuo-spatial learning in the first weeks of disease since, at later stages, mice were not able to learn the task adequately. A latent diabetes mellitus was found in all transgenic mice demonstrated by a pathological glucose tolerance. Only 26% of the mice, however, were found to develop a manifest diabetes with increasing blood glucose levels on normal diet over the disease period. R6/2 mice with manifest and latent diabetes showed no significant differences in survival, weight loss, motor coordination, or spontaneous explorative behavior. These results suggest that diabetes mellitus is not a major contributing factor to the disease phenotype.

Animals↗

PubMed1998

The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study.

OBJECTIVES: A birth cohort was followed-up to age 4 years to record the development of allergic disorders and to study the influence of genetic and environmental factors. METHODS: Information on family history and environmental factors was obtained at birth, and serum cord IgE was measured. At age 4 years, 1218 children were reviewed. RESULTS: By age 4 years, 27% of the children had symptoms of allergic disease. Period prevalence of asthma increased from 8.7% in infancy to 14.9% at 4 years. Family history of atopy was the single most important risk factor for atopy in children. Sibling atopy was a stronger predictor of clinical disease than maternal or paternal atopy, whereas paternal atopy, male sex, and high cord IgE were significant for the development of allergen sensitization. Children of asthmatic mothers were three times more likely to have asthma (odds ratio [OR]: 3.0, 95% confidence interval [CI]: 1.6-5.8) and rhinitis (OR: 2.9, CI: 1.1-7.4). Formula feeding before 3 months of age predisposed to asthma at age 4 years (OR: 1.8, CI: 1.2-2.6). The effect of maternal smoking on childhood wheeze seen at 1 and 2 years was lost by age 4, except for a subgroup with negative skin test responses (nonatopic asthma). Less than half (46%) of the infantile wheezers were still wheezing at 4 years of age. CONCLUSION: Family history of atopy remains the most important risk factor for atopy in children, but other markers can be identified with a potential for intervention at an early age.

Animals↗

PubMed2002

Effects of nitric oxide inhalation on periodic breathing in awake patients with chronic heart disease.

BACKGROUND: Periodic breathing, an abnormal pattern of respiration consisting of alternating hyperpnea and hypopnea, has been recognized in patients with heart failure. Although fluctuations in pulmonary blood flow have been considered as a possible cause of this type of breathing, its patho-physiological mechanisms are not fully understood. In this study, we sought to determine whether inhaled nitric oxide (NO), a selective pulmonary vasodilator, attenuates periodic breathing. METHODS: Eight cardiac patients who exhibited clear oscillatory ventilation while awake (age: 62 +/- 16 years, left ventricular ejection fraction: 48 +/- 20%) were enrolled in the study. After breathing room air (RA) for 15 min, the subjects inhaled air containing 30 ppm of NO for 15 min. Respiratory gas variables including minute ventilation (VE) were measured on a breath-by-breath basis throughout the test. RESULTS: There were no differences in VE (10.7 +/- 1.5 vs. 11.0 +/- 1.7 l/min) or among any of the other hemodynamic or respiratory gas variables studied in the control and NO tests, with the exception of the end-tidal CO(2) partial pressure (5.0 +/- 0.4 vs. 4.8 +/- 0.5%; p = 0.018). The % magnitude of oscillation (i.e., the difference between the peak and nadir of oscillating VE, divided by the mean VE) was 40.0 +/- 22.4% in RA and not influenced by inhaled NO (43.9 +/- 20.8%, p = 0.57). CONCLUSION: Inhaled NO at a concentration of 30 ppm did not attenuate periodic breathing in awake patients with mild heart failure.

Administration, Inhalation↗

PubMed1976

Natural remission of nephrotic syndrome in a dog with immune-complex glomerular disease.

A nephrotic syndrome caused by immune-complex glomerular disease was diagnosed in a 4-year-old male Great Dane. The syndrome was characterized by proteinuria, hypoproteinemia, hypoalbuminemia, hypercholesterolemia, and subcutaneous edema. Renal biopsy revealed segmental membranous glomerular disease. The edema underwent complete remission 18 days after admission. Two months after admission, there was no clinical or laboratory evidence of glomerular disease. Periodic reevaluation of the dog during the next 2 years revealed recurrence of proteinuria, but no other clinical or laboratory abnormalities. Serial renal biopsies revealed persistence, but no appreciable increase, in the severity of the segmental membranous glomerular disease. The natural course of the nephrotic syndrome and immune-complex glomerular disease has been associated with unpredictable variability. It was concluded that the widespread use of corticosteroid or immunosuppressant therapy in dogs with immune complex glomerular disease should be withheld until the natural course of the disease has been evaluated in a significant number of patients and until the results of well-controlled clinical studies confirm or deny their therapeutic value.

Animals↗

PubMedDate not supplied

Descriptive epidemiology of captive cervid herds in Michigan, USA.

A study was designed to determine the species composition, disease period prevalence, and utilization of preventive practices in captive cervid herds in Michigan. This is the first description of cervid farming in the United States. Data for the 12 months preceding the study were collected by means of a mail questionnaire conducted from March 3 through June 28, 1993. Completed questionnaires were returned by 228 of 362 (63%) farms. Study respondents reported ownership of a total of 4972 (80.9%) white-tailed deer (Odocoileus virginianus), 766 (12.5%) elk (Cervus elaphus canadensis), 284 (4.6%) fallow deer (Dama dama), 114 (1.9%) sika deer (Cervus nippon), 6 (0.1%) red deer (Cervus elaphus), 4 (< 0.1%) axis deer (Axis axis), and 2 (< 0.1%) caribou (Rangifer tarandus). The respondents provided disease data for 5493 captive cervids. The most frequent categories of illness in captive cervids (as determined by the period prevalence rates for the 12 months preceding the study) were injuries (1.9%), respiratory disorders (1.1%), foot and leg problems (1.0%), stress due to handling or transport (0.8%), and dystocia (0.8%). The most frequent causes of death were injuries (1.0%), respiratory disorders (0.8%), stress due to handling or transport (0.7%), and unknown causes (0.7%). Use of anthelmintics was reported by 173 of 219 (79%) farms. Only 13% [28/215] vaccinated their cervids. One hundred and fifty-nine of 219 farms reported having a veterinarian who provides cervid consultation. Services provided by these veterinarians include general consultation (58.5% [93/159]), treatment of injuries (27.7% [44/159]), anthelmintic administration (25.2% [40/159]), issuance of health certificates (19.5% [31/159]), diagnosis and treatment of illnesses (17.6% [28/159]), vaccination (13.8% [22/159]), disease diagnosis (treatment provided by farmer) (8.8% [14/159]), foot care (3.8% [6/159]), and other purposes (ie, necropsy, dystocia, antler removal) (11.3% [18/159]).

Animal Diseases↗

PubMed1991

[Indicators of erythro- and immunopoiesis in the development of autoimmune disease induced by graft vs host reaction].

Erythropoiesis and immunity are evaluated in (C57BL/6xDBA/2) F1 mice with immune complex glomerulonephritis induced by GVHR as compared to the genetically determined models of systemic lupus erythematosus. Elevated content of serum blood antinuclear antibodies, polyclonal activation during early disease periods, immune complex deposition in kidney tissues indicate the presence of the autoimmune syndrome in (C57BL/6xDBA/2)F1 mice, similar to that in mice with genetic lupus nephritis. The findings of a decrease of CFUs on days 5 and 8 at early times of disease, a reduction of hematocrit in combination with the enhancement of stem cell proliferation on the 6th-7th month of disease, an increase of the absolute leukocyte count and relative monocyte count in the peripheral blood of diseased mice may attest to the depression of stem cell differentiation in erythropoiesis and to the enhancement of stem cell differentiation in granulocyto-monocytopoiesis, that needs, however, further research and confirmation.

Animals↗

PubMed1995

ANCA and predicting relapse in systemic vasculitis.

We studied 60 patients with ANCA-positive systemic vasculitis (SV) to assess the prognostic significance of clinical and serological features at presentation, and the value of sequential monitoring of ANCA, C-reactive protein (CRP) and ESR levels as predictors of disease relapse. Patients were recruited at the time of diagnosis, treated with a standard protocol, and assessed monthly for one year. Clinical remission was achieved in 56/60 (93%), and ANCA became undetectable in 50/60 (83%) after treatment. During the one year follow-up period, disease relapses were seen in 23 (38%) patients. No specific associations were observed between initial disease presentation, initial ANCA level or ANCA antigenic specificity and relapse. However, 13/23 (57%) of relapses were preceded by a rise in ANCA a mean of 7.8 weeks earlier, while at the time of relapse 19/23 (83%) were ANCA-positive. Rises in CRP and ESR occurred in 23/60 (38%) and 14/43 (33%), respectively, but were less closely associated with relapse than ANCA. A sustained rise in ANCA was seen in six patients without relapse while clinical relapse occurred with a negative ANCA in four. Sequential ANCA monitoring at monthly intervals during disease remission is of value, at least during the first year, in the prediction and diagnosis of relapse in SV, and is superior to measurement of CRP or ESR.

Antibodies, Antineutrophil Cytoplasmic↗

PubMed2004

Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis.

A basic conservation of cell migration guidance mechanisms in the nervous and immune systems was proposed when Slit, known for its role in axon guidance, was found to inhibit chemokine-induced leukocyte chemotaxis in vitro. These studies examined the role of Slit2 in modulating inflammation in vivo. In a rat model of glomerulonephritis, endogenous glomerular Slit2 expression fell after disease induction, and its inhibition during the early disease period accelerated inflammation. Ex vivo glomerular leukocytes showed decreased chemokine and chemoattractant-induced chemotaxis in response to Slit2, suggesting an anti-inflammatory role for glomerular Slit2. In contrast to the effect of inhibition, glomerulonephritis was ameliorated by systemic Slit2 administration. Slit2 treatment improved disease histologically and also improved renal function when given early in the disease course. Leukocytes harvested from rats receiving Slit2 showed decreased monocyte chemoattractant protein-1 (MCP)-1-mediated migration, consistent with a peripheral Slit2 effect. In keeping with this functional alteration, Slit2-mediated inhibition of RAW264.7 cell chemotaxis was associated with decreased levels of active cdc42 and Rac1, implicating GTPases in leukocyte Slit2 signaling. These findings suggest a role for endogenous Slit2 in the inhibition of chemoattractant-mediated signals, demonstrate a potentially important anti-inflammatory effect for Slit2 in vivo, and provide further evidence for conserved mechanisms guiding the process of migration in distinct cell types.

Animals↗

PubMedDate not supplied

[Serratia-mastitis in cows as a herd problem].

Clinical mastitis with infection of Serratia marcescens occurred in a tied-up dairy herd in Sweden on a scale widely exceeding what has hitherto been reported in veterinary literature. The herd contained 37 milking cows before the disease period but only 14 at slaughter 21 months later in spite of some recruitment. A very large number of mastitis cases, usually rather mild and of short duration, had then occurred--during one single month not less than 47 cases. Hardly any cow escaped the disease. Instead, the single cows fell ill at short intervals with mastitis in the same quarter as previously or in another quarter. Antibiotic therapy in clinical cases, dry cow therapy and teat dipping had no obvious effect. Serratia marcescens was isolated in all 14 slaughtered cows in one or more quarters. The morphological changes were remarkably mild. Isolated Serratia strains revealed no distinctive marks compared with ordinary saprophytic strains in laboratory tests. Serratia-contaminated sawdust used as litter was possibly the source of infection and the milking machine possibly the tool for the transmission of bacteria to the udder, in the latter case by the aspiration of contaminated sawdust when the claw was attached or detached, or it fell off during milking. The pathogenicity of the bacteria and the susceptibility of the cows to udder infection may have been increased.

Animals↗

PubMed1989

Urinary tract disorders in patients with chronic granulomatous disease.

Twelve of the 25 patients with chronic granulomatous disease treated at our institution between 1957 and 1987 were found to have urinary tract disorders. All 12 patients were male and 22 years of age or younger when chronic granulomatous disease was diagnosed. Six patients had hydroureteronephrosis in association with recurrent episodes of pyelonephritis, retroperitoneal lymphadenitis, and granuloma formation. The other six patients had genital lesions or dysuria. Among the six patients with hydroureteronephrosis, a nephrectomy was performed in two, ureterolysis was used to relieve obstruction in one, and hydroureteronephrosis resolved after antibiotic therapy alone in three. We conclude that complications involving the genitourinary system occur frequently in patients with chronic granulomatous disease. Periodic imaging of the urinary tract may detect asymptomatic hydroureteronephrosis or other treatable genitourinary abnormalities in these patients.

Adolescent↗

PubMed1995

Malnutrition in hospitalized pediatric patients. Current prevalence.

OBJECTIVE: To document the current prevalence of protein-energy malnutrition compared with that reported from the same institution in 1976. DESIGN: All inpatients of this tertiary-care facility were assessed by anthropometric, laboratory, and clinical nutrition assessment methods in a 1-day cross-sectional survey. The comparison study from 1976 was also a 1-day cross-sectional survey. SETTING: A tertiary-care facility in Boston, Mass. PATIENTS: The entire inpatient population was assessed on a single weekday in September 1992. MAIN OUTCOME MEASURES: Prevalence of acute and chronic malnutrition as judged by anthropometric and laboratory data. Data on demographics, admission classification, underlying disease, route of nutrition, and global nutritional status were also assessed. RESULTS: The prevalence of acute protein-energy malnutrition (weight for height) based on the Waterlow criteria was as follows: severe, 1.3%; moderate, 5.8%; mild, 17.4%; and none, 75.5%. The prevalence of chronic protein-energy malnutrition (height for age) was as follows: severe, 5.1%; moderate, 7.7%; mild, 14.5%; and none, 72.8%. Although the prevalence of acute and chronic protein-energy malnutrition was significantly less in 1992 than in 1976 (P = .03 and P < .001, respectively), the numbers are still alarmingly high. Children younger than 2 years and older than 18 years and those with chronic medical conditions had a higher prevalence of protein-energy malnutrition. Twenty-four percent of patients had a serum albumin level less than 30 g/L, 34.8% had a total lymphocyte count less than 1.5 x 10(9)/L, and 24.9% had a hemoglobin concentration less than 105 g/L. One fourth of all patients were obese (> 120% weight for height), with the greatest prevalence in children aged 2 to 18 years. CONCLUSIONS: Acute and chronic protein-energy malnutrition remains common in hospitalized pediatric patients in the United States. Important risk factors may be underlying chronic disease, periods of normally rapid growth, and recognized need for nutrition intervention.

Acute Disease↗

PubMed1995

[Electric gustatory threshold in diabetics and its clinical significance].

Electrogustometry was performed in diabetics and the correlation between the electric gustatory threshold and clinical factors of the patients (age, disease period and diabetic complications) were evaluated (n = 50). The results obtained were as follows: 1. The electric gustatory threshold rose with aging. The patient age range for further analysis was confined to 50 approximately 69 years old (n = 34) to exclude age dependency. 2. The patients with longer disease histories tended to show a higher electric gustatory threshold, indicating that taste abnormalities in diabetics progress with disease duration. 3. Elevation of the electric gustatory threshold in diabetics was observed before onset or at the earliest stage of the three major complications (diabetic neuropathy, retinopathy and nephropatho), and the threshold rose further with the progression of diabetic complications. Thus, the electric gustatory threshold is a sensitive indicator of diabetic nephropathy and was demonstrated to be a remarkably useful indicator for the prevention of diabetic complications, since it allows detection of the three major diabetic complications at their earliest stages.

Adult↗

PubMed1990

[Hemostasis in influenza and acute respiratory viral infections in the middle-aged and elderly].

Hemostasis was examined over time in 168 patients with influenza and ARVI. There were 53 elderly patients, 54 senile patients and 4 long-livers. 57 patients under 60 years made up a reference group. The patients with influenza did not differ significantly from those with ARVI as regards hemostasis. The elderly persons manifested pronounced acceleration of phases I-II blood coagulation. In the acute disease period, the old men demonstrated high platelet aggregation, whereas during convalescence, activation of the plasmic component of hemostasis in the presence of relatively low antithrombin III. Analysis was also made of the age-associated changes in hemostasis depending on influenza and ARVI complications (pneumonia, exacerbation of coronary disease, bronchitis). The changes revealed dictate the necessity of hemostasis control in elderly and senile persons afflicted with influenza and ARVI.

Acute Disease↗

PubMed1997

Evaluation of decoquinate to treat experimental cryptosporidiosis in kids.

The purpose of this trial was to evaluate the effects of decoquinate at 2.5 mg/kg/day for 21 days to prevent an experimental cryptosporidiosis in kids. Twenty 1-day-old male kids (French Alpin), fed initially goat colostrum heated 1 h at 56 degrees C and fed twice daily with nonmedicated milk replacer, were assigned into 2 groups. Kids of both groups were orally inoculated with 10(6) Cryptosporidium parvum (D0 = inoculation day). Group A kids were kept as nonmedicated controls and group B kids were orally medicated with 2.5 mg/kg/day of decoquinate (Deccox L. Rhône Poulenc Animal Nutrition) for 21 days from D-3 to D17. The studied criteria were body weight gain, oocyst shedding and specific anti-C. parvum immune response. In group A, the inoculation was not followed by mortality; but only by diarrhea and high oocyst shedding. Decoquinate reduced the severity of cryptosporidiosis in group B kids. The treatment prevented episodes of diarrhea and weight gain decrease for the D0-D7 and D0-D14 disease periods but did not allow a better final weight gain. The oocyst shedding was decreased in number and in duration. This parasitic development has induced a specific anti-C. parvum immune response. This drug is well-tolerated by animals and may be recommended in the prevention of ruminant cryptosporidiosis, a disease which has very limited treatment options.

Animals↗

PubMed1997

Laboratory findings in cows after experimental infection with Ehrlichia phagocytophila.

The goal of this study was to assess various hematological variables in 10 cows after experimental infection with Ehrlichia phagocytophila. Blood samples were collected at regular intervals for examination of leukocytes for Ehrlichia organisms and for determination of hematological and biochemical variables. In addition, PCR amplification was performed throughout the disease period on blood and milk samples for the detection of E. phagocytophila organisms. The time of seroconversion and the duration of serum titers indicating positivity were determined by indirect immunofluorescence. For all cows, E. phagocytophila organisms were first detected microscopically in leukocytes 5 to 8 days postinfection and could be demonstrated for a period of 6 to 14 days. For all cows, the appearance of E. phagocytophila organisms in leukocytes coincided with transient erythropenia, leukopenia, and thrombocytopenia and a decrease in hematocrit and hemoglobin concentration. For five lactating cows, E. phagocytophila organisms were identified in leukocytes of milk samples during the acute phase of the disease, which, we believe, has not previously been reported. E. phagocytophila DNA was detected in blood samples by nested PCR from 1 to 2 days before to 2 to 12 days after the organisms were identified microscopically. In milk samples, E. phagocytophila DNA was detected for an average of 11 days.

Animals↗

PubMed1990

[Functional activity of segmentonuclear neutrophils and monocytes in children with different cytologic variants of acute myeloid leukemia].

Bone marrow and blood neutrophils and monocytes were examined over time in 31 patients with different versions of acute myeloid leukemia according to the phagocytosis and NBT tests. As compared to the phagocytic indicators in healthy children, the absorptive activity in the acute disease period was increased and the digestive activity was lowered. Approximation of the digestive activity of blood neutrophils to the control data was only noted in long remissions (over 1 year). Function of mature cells together with other markers can be used as an initial sign of a favourable prognosis of the underlying disease.

Child↗

PubMed1990

[Clinical course of recurrent schizophrenia].

As many as 79 patients suffering from many-attack schizophrenia going with short-term remissions were examined. Four major variants of the disease dynamics were distinguished with regard to the disease stereotype. The first variant was characterized by the retention of liability to relapsing and occurrence of acute attacks throughout the whole disease period, the second one by deceleration and amelioration of the attacks, the third one by the loss of tendencies towards attack occurrence and formation of long remissions, and the fourth variety by transition to the chronic psychotic state. The clinico-dynamic features of the indicated varieties are described. The prognostic criteria for the disease outcome are defined.

Adult↗